Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

• Main Authors: Albert Cornelius (Author), Jessica Foley (Author), Jeffrey Bond (Author), Abhinav B. Nagulapally (Author), Julie Steinbrecher (Author), William P. D. Hendricks (Author), Maria Rich (Author), Sangeeta Yendrembam (Author), Genevieve Bergendahl (Author), Jeffrey M. Trent (Author), Giselle S. Sholler (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Choroid plexus carcinomas (CPCs) are rare, aggressive pediatric brain tumors with no established curative therapy for relapsed disease, and poor survival rates. TP53 Mutation or dysfunction correlates with poor or no survival outcome in CPCs. Here, we report the case of a 4 month-old female who pres...